StreptococCus faecalls 30MIlI, Clostrldlum butyricum 2Mill, Bacillus mesentericus 1Mill + Lactic acid Bacillus 50MillCapsulee

StreptococCus faecalls 30MIlI, Clostrldlum butyricum 2Mill, Bacillus mesentericus 1Mill + Lactic acid Bacillus 50MillCapsulee is a capsule formulated with StreptococCus faecalls 30MIlI, Clostrldlum butyricum 2Mill, Bacillus mesentericus 1Mill + Lactic acid Bacillus 50MillCapsulee. The listed active ingredient profile is StreptococCus faecalls 30MIlI; Clostrldlum butyricum 2Mill; Bacillus mesentericus 1Mill; Lactic acid Bacillus 50MillCapsulee, placing the product in the probiotic / gastrointestinal support category. The formulation provides selected probiotic organisms and/or supportive nutritional components for gastrointestinal microbial support. The source indicates enteric coated characteristics, which should be retained exactly because release technology can affect administration and product performance. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.